These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30953513)

  • 1. Highly glycosylated CD147 promotes hemorrhagic transformation after rt-PA treatment in diabetes: a novel therapeutic target?
    Xie Y; Wang Y; Ding H; Guo M; Wang X; Dong Q; Cui M
    J Neuroinflammation; 2019 Apr; 16(1):72. PubMed ID: 30953513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
    Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
    Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke.
    Li Y; Chen J; Quan X; Chen Y; Han Y; Chen J; Yang L; Xu Y; Shen X; Wang R; Zhao Y
    Int J Nanomedicine; 2024; 19():1451-1467. PubMed ID: 38371456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of tamoxifen on CD147 glycosylation and MMPs in the diabetic rat myocardium].
    Wang YX; Gao YT; Cui LB; Ru NY; Zhang HJ; Jiao B; Yu ZB
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Jan; 31(1):1-5. PubMed ID: 26016225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
    Jin R; Xiao AY; Chen R; Granger DN; Li G
    Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
    J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
    Shan Y; Tan S; Lin Y; Liao S; Zhang B; Chen X; Wang J; Deng Z; Zeng Q; Zhang L; Wang Y; Hu X; Qiu W; Peng L; Lu Z
    J Neuroinflammation; 2019 Nov; 16(1):242. PubMed ID: 31779652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke.
    Liu B; Li Y; Han Y; Wang S; Yang H; Zhao Y; Li P; Wang Y
    Phytomedicine; 2021 Sep; 90():153660. PubMed ID: 34344565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase (MMP) induction and inhibition at different doses of recombinant tissue plasminogen activator following experimental stroke.
    Burggraf D; Martens HK; Dichgans M; Hamann GF
    Thromb Haemost; 2007 Nov; 98(5):963-9. PubMed ID: 18000599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator treatment of stroke in type-1 diabetes rats.
    Ning R; Chopp M; Yan T; Zacharek A; Zhang C; Roberts C; Cui X; Lu M; Chen J
    Neuroscience; 2012 Oct; 222():326-32. PubMed ID: 22820263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sasidhar MV; Chevooru SK; Eickelberg O; Hartung HP; Neuhaus O
    PLoS One; 2017; 12(12):e0189701. PubMed ID: 29253870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective knockout of astrocytic Na
    Begum G; Song S; Wang S; Zhao H; Bhuiyan MIH; Li E; Nepomuceno R; Ye Q; Sun M; Calderon MJ; Stolz DB; St Croix C; Watkins SC; Chen Y; He P; Shull GE; Sun D
    Glia; 2018 Jan; 66(1):126-144. PubMed ID: 28925083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration.
    Gubern-Mérida C; Comajoan P; Huguet G; García-Yebenes I; Lizasoain I; Moro MA; Puig-Parnau I; Sánchez JM; Serena J; Kádár E; Castellanos M
    Mol Neurobiol; 2022 Feb; 59(2):1320-1332. PubMed ID: 34984586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban does not influence hemorrhagic transformation in a diabetes ischemic stroke and endovascular thrombectomy model.
    Liu FD; Zhao R; Feng XY; Shi YH; Wu YL; Shen XL; Li GF; Liu YS; Zhao Y; He XW; Yin JW; Zhuang MT; Zhao BQ; Liu JR
    Sci Rep; 2018 May; 8(1):7408. PubMed ID: 29743683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.
    Liu J; Jin X; Liu KJ; Liu W
    J Neurosci; 2012 Feb; 32(9):3044-57. PubMed ID: 22378877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.
    Jin X; Sun Y; Xu J; Liu W
    J Neurochem; 2015 Mar; 132(6):724-30. PubMed ID: 25683686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.